gallium has been researched along with Minimal Disease, Residual in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dzhumabaeva, BT; Gotman, LN; Iskhakov, ED; Kaplanskaia, IB; Kravchenko, SK; Sagdieva, NSh; Sakhibov, IaD; Shavlokhov, VS; Shevelev, AA | 1 |
| Attal, M; Coiffier, B; Deconinck, E; Doyen, C; Gaulard, P; Gisselbrecht, C; Haioun, C; Lepage, E; Morel, P; Reyes, F; Tilly, H | 1 |
| Bombardieri, E; Castellani, M; Devizzi, L; Gasparini, M; Gerundini, P; Maffioli, L; Tondini, C | 1 |
| Chen, JL; Frohlich, DE; Kehoe, KM; Neuberg, D; Van den Abbeele, AD | 1 |
| Ricart, Y | 1 |
1 review(s) available for gallium and Minimal Disease, Residual
| Article | Year |
|---|---|
High-dose therapy followed by stem cell transplantation in partial response after first-line induction therapy for aggressive non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Free Survival; Gallium; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Neoplasm Staging; Neoplasm, Residual; Randomized Controlled Trials as Topic; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome | 1998 |
4 other study(ies) available for gallium and Minimal Disease, Residual
| Article | Year |
|---|---|
[Gamma-scintigraphy with Ga-67 citrate in differential diagnosis of residual tumors in lymphogranulomatosis and lymphosarcoma].
Topics: Adolescent; Adult; Biopsy; Citrates; Diagnosis, Differential; Female; Gallium; Gamma Rays; Hodgkin Disease; Humans; Lymphoma, Non-Hodgkin; Male; Mediastinum; Middle Aged; Neoplasm, Residual; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Gallium-67 scintigraphy evaluation of therapy in non-Hodgkin's lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Citrates; Female; Gallium; Gallium Radioisotopes; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy, Adjuvant; Survival Analysis | 1998 |
When is hilar uptake of 67Ga-citrate indicative of residual disease after CHOP chemotherapy?
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Citrates; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Gallium; Gallium Radioisotopes; Humans; Lung; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm, Residual; Predictive Value of Tests; Prednisone; Retrospective Studies; Time Factors; Tomography, Emission-Computed, Single-Photon; Vincristine | 2000 |
[67-Gallium citrate gammagraphy in the study of lymphomas].
Topics: Citrates; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Gallium; Gallium Radioisotopes; Humans; Lymphoma; Neoplasm Recurrence, Local; Neoplasm Staging; Neoplasm, Residual; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2002 |